{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:10:40Z","timestamp":1782976240559,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,12,9]],"date-time":"2012-12-09T00:00:00Z","timestamp":1355011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s10549-012-2361-5","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T08:20:54Z","timestamp":1354954854000},"page":"571-577","source":"Crossref","is-referenced-by-count":49,"title":["Impact of breast cancer on anti-mullerian hormone levels in young women"],"prefix":"10.1007","volume":"137","author":[{"given":"H. I.","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. W.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"DeMichele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Z.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,9]]},"reference":[{"key":"2361_CR1","unstructured":"DevCan: Probability of Developing or Dying of Cancer Software VSRaABNCI, 2012. www.srab.cancer.gov\/devcan"},{"issue":"22","key":"2361_CR2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJM197311292892202","volume":"289","author":"GL Warne","year":"1973","unstructured":"Warne GL, Fairley KF, Hobbs JB, Martin FI (1973) Cyclophosphamide-induced ovarian failure. N Engl J Med 289(22):1159\u20131162","journal-title":"N Engl J Med"},{"issue":"10","key":"2361_CR3","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/humrep\/del201","volume":"21","author":"RA Anderson","year":"2006","unstructured":"Anderson RA, Themmen AP, Al-Qahtani A, Groome NP, Cameron DA (2006) The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 21(10):2583\u20132592","journal-title":"Hum Reprod"},{"issue":"3","key":"2361_CR4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/cncr.24746","volume":"116","author":"HI Su","year":"2010","unstructured":"Su HI, Sammel MD, Green J, Velders L, Stankiewicz C, Matro J, Freeman EW, Gracia CR, DeMichele A (2010) Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer 116(3):592\u2013599","journal-title":"Cancer"},{"issue":"1","key":"2361_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3816\/CBC.2008.n.004","volume":"8","author":"AH Partridge","year":"2008","unstructured":"Partridge AH, Gelber S, Peppercorn J, Ginsburg E, Sampson E, Rosenberg R, Przypyszny M, Winer EP (2008) Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer 8(1):65\u201369","journal-title":"Clin Breast Cancer"},{"issue":"5","key":"2361_CR6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1200\/JCO.2007.14.1655","volume":"26","author":"LR Schover","year":"2008","unstructured":"Schover LR (2008) Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 26(5):753\u2013758","journal-title":"J Clin Oncol"},{"issue":"3","key":"2361_CR7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/humrep\/deh671","volume":"20","author":"G Bahadur","year":"2005","unstructured":"Bahadur G, Ozturk O, Muneer A, Wafa R, Ashraf A, Jaman N, Patel S, Oyede AW, Ralph DJ (2005) Semen quality before and after gonadotoxic treatment. Hum Reprod 20(3):774\u2013781","journal-title":"Hum Reprod"},{"issue":"12","key":"2361_CR8","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1093\/humrep\/17.12.3157","volume":"17","author":"G Bahadur","year":"2002","unstructured":"Bahadur G, Ling KL, Hart R, Ralph D, Wafa R, Ashraf A, Jaman N, Mahmud S, Oyede AW (2002) Semen quality and cryopreservation in adolescent cancer patients. Hum Reprod 17(12):3157\u20133161","journal-title":"Hum Reprod"},{"issue":"4","key":"2361_CR9","first-page":"259","volume":"35","author":"HI Su","year":"2010","unstructured":"Su HI (2010) Measuring ovarian function in young cancer survivors. Minerva Endocrinol 35(4):259\u2013270","journal-title":"Minerva Endocrinol"},{"issue":"6","key":"2361_CR10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","volume":"12","author":"FJ Broekmans","year":"2006","unstructured":"Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB (2006) A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 12(6):685\u2013718","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2361_CR11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.fertnstert.2006.11.006","volume":"87","author":"DJ Hendriks","year":"2007","unstructured":"Hendriks DJ, Kwee J, Mol BW, te Velde ER, Broekmans FJ (2007) Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril 87(4):764\u2013775","journal-title":"Fertil Steril"},{"issue":"9","key":"2361_CR12","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/dep210","volume":"24","author":"A Marca La","year":"2009","unstructured":"La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS (2009) Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod 24(9):2264\u20132275","journal-title":"Hum Reprod"},{"issue":"5","key":"2361_CR13","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/jc.2011-3032","volume":"97","author":"EW Freeman","year":"2012","unstructured":"Freeman EW, Sammel MD, Lin H, Gracia CR (2012) Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 97(5):1673\u20131680","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2361_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A Marca La","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A (2010) Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 16(2):113\u2013130","journal-title":"Hum Reprod Update"},{"issue":"4 Suppl","key":"2361_CR15","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.fertnstert.2008.07.1727","volume":"91","author":"JM Knopman","year":"2009","unstructured":"Knopman JM, Noyes N, Talebian S, Krey LC, Grifo JA, Licciardi F (2009) Women with cancer undergoing ART for fertility preservation: a cohort study of their response to exogenous gonadotropins. Fertil Steril 91(4 Suppl):1476\u20131478","journal-title":"Fertil Steril"},{"issue":"3","key":"2361_CR16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.fertnstert.2008.10.007","volume":"93","author":"RB Quintero","year":"2010","unstructured":"Quintero RB, Helmer A, Huang JQ, Westphal LM (2010) Ovarian stimulation for fertility preservation in patients with cancer. Fertil Steril 93(3):865\u2013868","journal-title":"Fertil Steril"},{"issue":"2","key":"2361_CR17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.fertnstert.2010.04.028","volume":"95","author":"AD Robertson","year":"2011","unstructured":"Robertson AD, Missmer SA, Ginsburg ES (2011) Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy. Fertil Steril 95(2):588\u2013591","journal-title":"Fertil Steril"},{"issue":"7","key":"2361_CR18","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/13.7.1837","volume":"13","author":"L Pal","year":"1998","unstructured":"Pal L, Leykin L, Schifren JL, Isaacson KB, Chang YC, Nikruil N, Chen Z, Toth TL (1998) Malignancy may adversely influence the quality and behaviour of oocytes. Hum Reprod 13(7):1837\u20131840","journal-title":"Hum Reprod"},{"issue":"4","key":"2361_CR19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.fertnstert.2012.01.093","volume":"97","author":"J Domingo","year":"2012","unstructured":"Domingo J, Guillen V, Ayllon Y, Martinez M, Munoz E, Pellicer A, Garcia-Velasco JA (2012) Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril 97(4):930\u2013934","journal-title":"Fertil Steril"},{"issue":"1","key":"2361_CR20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.fertnstert.2006.05.074","volume":"87","author":"EW Freeman","year":"2007","unstructured":"Freeman EW, Gracia CR, Sammel MD, Lin H, Lim LC, Strauss JF 3rd (2007) Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril 87(1):101\u2013106","journal-title":"Fertil Steril"},{"key":"2361_CR21","doi-asserted-by":"crossref","DOI":"10.1201\/9780429246593","volume-title":"An introduction to the bootstrap","author":"BT Efron","year":"1994","unstructured":"Efron BT, Tibshirani RJ (1994) An introduction to the bootstrap. CRC Press, Boca Raton"},{"issue":"4","key":"2361_CR22","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/AOG.0b013e3182116bc8","volume":"117","author":"AZ Steiner","year":"2010","unstructured":"Steiner AZ, Herring AH, Kesner JS, Meadows JW, Stanczyk FZ, Hoberman S, Baird DD (2010) Antimullerian hormone as a predictor of natural fecundability in women aged 30\u201342\u00a0years. Obstet Gynecol 117(4):798\u2013804","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2361_CR23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.fertnstert.2011.04.070","volume":"96","author":"M Das","year":"2011","unstructured":"Das M, Shehata F, Moria A, Holzer H, Son WY, Tulandi T (2011) Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancy. Fertil Steril 96(1):122\u2013125","journal-title":"Fertil Steril"},{"issue":"5","key":"2361_CR24","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.fertnstert.2010.12.041","volume":"95","author":"A Moria","year":"2011","unstructured":"Moria A, Das M, Shehata F, Holzer H, Son WY, Tulandi T (2011) Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatment. Fertil Steril 95(5):1621\u20131623","journal-title":"Fertil Steril"},{"issue":"9","key":"2361_CR25","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.25037","volume":"116","author":"B Yu","year":"2010","unstructured":"Yu B, Douglas N, Ferin MJ, Nakhuda GS, Crew K, Lobo RA, Hershman DL (2010) Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy. Cancer 116(9):2099\u20132105","journal-title":"Cancer"},{"issue":"1","key":"2361_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.fertnstert.2012.04.021","volume":"98","author":"B Lawrenz","year":"2012","unstructured":"Lawrenz B, Fehm T, von Wolff M, Soekler M, Huebner S, Henes J, Henes M (2012) Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma-evaluation by using antimullerian hormone and retrieved oocytes. Fertil Steril 98(1):141\u2013144","journal-title":"Fertil Steril"},{"issue":"3","key":"2361_CR27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/gme.0b013e3181c7deba","volume":"17","author":"BJ Plante","year":"2010","unstructured":"Plante BJ, Cooper GS, Baird DD, Steiner AZ (2010) The impact of smoking on antimullerian hormone levels in women aged 38\u201350\u00a0years. Menopause 17(3):571\u2013576","journal-title":"Menopause"},{"issue":"7","key":"2361_CR28","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/humrep\/dem105","volume":"22","author":"WJ Hehenkamp","year":"2007","unstructured":"Hehenkamp WJ, Volkers NA, Broekmans FJ, de Jong FH, Themmen AP, Birnie E, Reekers JA, Ankum WM (2007) Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod 22(7):1996\u20132005","journal-title":"Hum Reprod"},{"issue":"12","key":"2361_CR29","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","volume":"21","author":"A Marca La","year":"2006","unstructured":"La Marca A, Stabile G, Artenisio AC, Volpe A (2006) Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod 21(12):3103\u20133107","journal-title":"Hum Reprod"},{"issue":"7","key":"2361_CR30","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/dem101","volume":"22","author":"S Tsepelidis","year":"2007","unstructured":"Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy C, Englert Y (2007) Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod 22(7):1837\u20131840","journal-title":"Hum Reprod"},{"issue":"3","key":"2361_CR31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.fertnstert.2011.06.016","volume":"96","author":"HW Li","year":"2011","unstructured":"Li HW, Anderson RA, Yeung WS, Ho PC, Ng EH (2011) Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea. Fertil Steril 96(3):774\u2013779","journal-title":"Fertil Steril"},{"issue":"4","key":"2361_CR32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.rbmo.2011.06.011","volume":"23","author":"SM Nelson","year":"2012","unstructured":"Nelson SM, La Marca A (2012) The journey from the old to the new AMH assay: how to avoid getting lost in the values. Reprod Biomed Online 23(4):411\u2013420","journal-title":"Reprod Biomed Online"},{"issue":"1\u20132","key":"2361_CR33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2010.08.011","volume":"362","author":"A Kumar","year":"2010","unstructured":"Kumar A, Kalra B, Patel A, McDavid L, Roudebush WE (2010) Development of a second generation anti-Mullerian hormone (AMH) ELISA. J Immunol Methods 362(1\u20132):51\u201359","journal-title":"J Immunol Methods"},{"issue":"8","key":"2361_CR34","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.fertnstert.2011.01.126","volume":"95","author":"JR Lee","year":"2011","unstructured":"Lee JR, Kim SH, Jee BC, Suh CS, Kim KC, Moon SY (2011) Antimullerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits. Fertil Steril 95(8):2602\u20132604","journal-title":"Fertil Steril"},{"issue":"1","key":"2361_CR35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.fertnstert.2007.10.067","volume":"91","author":"I Streuli","year":"2009","unstructured":"Streuli I, Fraisse T, Chapron C, Bijaoui G, Bischof P, de Ziegler D (2009) Clinical uses of anti-Mullerian hormone assays: pitfalls and promises. Fertil Steril 91(1):226\u2013230","journal-title":"Fertil Steril"},{"issue":"1\u20132","key":"2361_CR36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2006.06.013","volume":"375","author":"T Freour","year":"2007","unstructured":"Freour T, Mirallie S, Bach-Ngohou K, Denis M, Barriere P, Masson D (2007) Measurement of serum anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chim Acta 375(1\u20132):162\u2013164","journal-title":"Clin Chim Acta"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2361-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-012-2361-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2361-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T01:32:23Z","timestamp":1714699943000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-012-2361-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,9]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2361"],"URL":"https:\/\/doi.org\/10.1007\/s10549-012-2361-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,9]]}}}